Değerli, E.; Arslan, Ç.; Selçukbiricik, F.; Ölmez, Ö.F.; Erdem, D.; Hamdard, J.; Yılmaz, M.; Çolak, R.; Kapar, C.; Erman, M.;
et al. Association Between Baseline and Changes in Early Neutrophil-to-Lymphocyte Ratio on Survival in Patients with Metastatic Bladder Carcinoma Treated with Immunotherapy. Medicina 2024, 60, 2103.
https://doi.org/10.3390/medicina60122103
AMA Style
Değerli E, Arslan Ç, Selçukbiricik F, Ölmez ÖF, Erdem D, Hamdard J, Yılmaz M, Çolak R, Kapar C, Erman M,
et al. Association Between Baseline and Changes in Early Neutrophil-to-Lymphocyte Ratio on Survival in Patients with Metastatic Bladder Carcinoma Treated with Immunotherapy. Medicina. 2024; 60(12):2103.
https://doi.org/10.3390/medicina60122103
Chicago/Turabian Style
Değerli, Ezgi, Çağatay Arslan, Fatih Selçukbiricik, Ömer Fatih Ölmez, Dilek Erdem, Jamshid Hamdard, Mesut Yılmaz, Rumeysa Çolak, Caner Kapar, Mustafa Erman,
and et al. 2024. "Association Between Baseline and Changes in Early Neutrophil-to-Lymphocyte Ratio on Survival in Patients with Metastatic Bladder Carcinoma Treated with Immunotherapy" Medicina 60, no. 12: 2103.
https://doi.org/10.3390/medicina60122103
APA Style
Değerli, E., Arslan, Ç., Selçukbiricik, F., Ölmez, Ö. F., Erdem, D., Hamdard, J., Yılmaz, M., Çolak, R., Kapar, C., Erman, M., Kuş, F., & Tural, D.
(2024). Association Between Baseline and Changes in Early Neutrophil-to-Lymphocyte Ratio on Survival in Patients with Metastatic Bladder Carcinoma Treated with Immunotherapy. Medicina, 60(12), 2103.
https://doi.org/10.3390/medicina60122103
